EX CORONEL CUBANO REITERA QUE CUBA DESARROLLA ARMAS BIOLÓGICAS
Tweet
Según Ortega, Cuba está dispuesta a usar tales armas para chantaje en una situación de crisis internacional, por ejemplo, ante la amenaza de una invasión militar estadounidense contra la isla, escribe el periódico Miami Herald. Ortega confiesa haber visitado ese laboratorio una sola vez, en
1992, cuando acompañaba supuestamente a una delegación de altos cargos militares de Rusia. Esta afirmación es cuestionada por otro militar desertor, Kenneth Alibek,, que es como se llama ahora el ex coronel teniente del Ejército soviético Kanatzhan Alibekov, residente en Virginia. Le parece poco creíble que los cubanos hubieran invitado a militares rusos a una instalación de este tipo. (NdR: Sin embargo el propio Kenneth Alibek, ha sostenido que tiene fuertes razones para creer que los cubanos tienen un programa de desarrollo de armas biológicas.). El profesor Manuel Cereijo, principal experto de la Universidad de Miami en materia de biotecnologías cubanas, también pone en tela de juicio las afirmaciones de Ortega. Éste menciona un lugar del que Cereijo no ha oído nunca. Existen numerosos lugares donde los cubanos podrían producir armas biológicas, lo cual no significa que lo estén haciendo, señala él en una entrevista a Miami Herald.
********************
EX CORONEL CUBANO REITERA QUE CUBA DESARROLLA ARMAS BIOLÓGICAS
Nueva York
E.U.
RIA Novosti
Infosearch:
José F. Sánchez
Analista
Jefe de Buró
Cuba
Dept. de Investigaciones
La Nueva Cuba
Marzo 2, 2007
Roberto Ortega, quien había sido jefe del servicio médico de las Fuerzas Armadas de Cuba en el período de 1984-1994, declaró durante su intervención en el Instituto de estudios cubanos y cubanoamericanos de la Universidad de Miami que en las afueras de La Habana hay un laboratorio subterráneo, Labor Uno, cuyas investigaciones apuntan al desarrollo de armas biológicas a partir de los bacilos de la peste bubónica, el ántrax y la fiebre amarilla.
Según Ortega, Cuba está dispuesta a usar tales armas para chantaje en una situación de crisis internacional, por ejemplo, ante la amenaza de una invasión militar estadounidense contra la isla, escribe el periódico Miami Herald. Ortega confiesa haber visitado ese laboratorio una sola vez, en
1992, cuando acompañaba supuestamente a una delegación de altos cargos militares de Rusia. Esta afirmación es cuestionada por otro militar desertor, Kenneth Alibek,, que es como se llama ahora el ex coronel teniente del Ejército soviético Kanatzhan Alibekov, residente en Virginia. Le parece poco creíble que los cubanos hubieran invitado a militares rusos a una instalación de este tipo. (NdR: Sin embargo el propio Kenneth Alibek, ha sostenido que tiene fuertes razones para creer que los cubanos tienen un programa de desarrollo de armas biológicas.). El profesor Manuel Cereijo, principal experto de la Universidad de Miami en materia de biotecnologías cubanas, también pone en tela de juicio las afirmaciones de Ortega. Éste menciona un lugar del que Cereijo no ha oído nunca. Existen numerosos lugares donde los cubanos podrían producir armas biológicas, lo cual no significa que lo estén haciendo, señala él en una entrevista a Miami Herald.********************
Ken Alibek (Kanatjan Alibekov)
1950-
BBC News
Mayo 9, 2002
Originally called Kanatjan Alibekov, Ken Alibek changed his name when he defected to the US in 1992. He was born in 1950 in the Soviet Republic of Kazakhstan. At 17 he went to the medical instit
ute in Alma-Ata to train as a doctor. After four years he specialised in military medicine, enlisted in the army and went to be a cadet at the medical institute in Tomsk, Siberia. There he specialised in infectious diseases and epidemiology.
His first job after graduating in 1975 was with Biopreparat - an organisation established in Russia in 1973 which was ostensibly a state-owned pharmaceutical facility developing drugs and vaccines, but in fact was a front for the USSR's secret offensive bio weapons programme.
He quickly rose through the ranks and in 1983 became director of a huge bio-weapons research and production facility in Stepnogorsk. In 1987, when he was only 37, Alibek went to Moscow to become chief scientist and first deputy director of Biopreparat. During this time he supervised the development and production of an 'improved' smallpox weapon.
Alibek says he felt justified at the time in being involved in the Soviet bio-weapons programme, although it violated the 1972 Biological Weapons Convention, because he had believed that the US and Britain were engaged on clandestine bio-weapons programmes of their own. Alibek began to have grave doubts following an inspection visit to the US in 1991 in which, contrary to his expectations, he saw no evidence of an active biowarfare programme. The visit lasted from December to January 1992.
While he was away, Mikhail Gorbachev resigned as President and the Soviet Union became 15 independent republics. After his return to Russia Alibek resigned from Biopreparat and returned to Kazakhstan. He was asked by the new Kazakhstani government to establish a bio-weapons programme but refused. He went to the US in October 1992 and spent most of the next year being debriefed by the CIA.
Dr Alibek is now a US citizen and Chief Scientist at a private company in the US that specialises in researching and developing medical defences against biological weapons.
*************
1950-
BBC News
Mayo 9, 2002
Originally called Kanatjan Alibekov, Ken Alibek changed his name when he defected to the US in 1992. He was born in 1950 in the Soviet Republic of Kazakhstan. At 17 he went to the medical instit
ute in Alma-Ata to train as a doctor. After four years he specialised in military medicine, enlisted in the army and went to be a cadet at the medical institute in Tomsk, Siberia. There he specialised in infectious diseases and epidemiology.His first job after graduating in 1975 was with Biopreparat - an organisation established in Russia in 1973 which was ostensibly a state-owned pharmaceutical facility developing drugs and vaccines, but in fact was a front for the USSR's secret offensive bio weapons programme.
He quickly rose through the ranks and in 1983 became director of a huge bio-weapons research and production facility in Stepnogorsk. In 1987, when he was only 37, Alibek went to Moscow to become chief scientist and first deputy director of Biopreparat. During this time he supervised the development and production of an 'improved' smallpox weapon.
Alibek says he felt justified at the time in being involved in the Soviet bio-weapons programme, although it violated the 1972 Biological Weapons Convention, because he had believed that the US and Britain were engaged on clandestine bio-weapons programmes of their own. Alibek began to have grave doubts following an inspection visit to the US in 1991 in which, contrary to his expectations, he saw no evidence of an active biowarfare programme. The visit lasted from December to January 1992.
While he was away, Mikhail Gorbachev resigned as President and the Soviet Union became 15 independent republics. After his return to Russia Alibek resigned from Biopreparat and returned to Kazakhstan. He was asked by the new Kazakhstani government to establish a bio-weapons programme but refused. He went to the US in October 1992 and spent most of the next year being debriefed by the CIA.
Dr Alibek is now a US citizen and Chief Scientist at a private company in the US that specialises in researching and developing medical defences against biological weapons.
*************
RUSSIAN EXPERT: 'STRONG SUSPICIONS' OF CUBAN BIO THREAT
By Dave Eberhart
NewsMax
La Nueva Cuba
May 22, 2002
The former head of Russia's biological weapons program and the man considered to be the foremost expert in the field of bioweapons told NewsMax he has "strong suspicions" that Cuba is developing deadly pathogens.
Questions about Cuba's biological development program were defined recently by three separate charges.
First, an undersecretary of state announced, "The U.S believes that Cuba has at least a limited offensive biological warfare research and development effort."
Second, a spokesman for dictator Fidel Castro dismissed the slur as "loathsome." And finally, former President Jimmy Carter chimed in that the U.S. had no hard evidence that Cuba is sending material for terrorist weapons to other nations.
The foremost expert on the controversial subject, 1992 defector to the U.S. and author of "Biohazard, Dr. Ken Alibek, said he suspects the Bush administration is correct when it says Cuba is developing deadly germ agents.
Alibek notes that a bioweapons program can be masked easily by a civilian-purpose biotechnology effort.
Alibek drew a parallel with Iraq, which he says in the 1980s ran an infamous program to turn the smallpox virus into a biological weapon for the Soviets.
The Iraqis, he said, used the guise of single-cell protein production as a cover for biological weapons facilities.
Russia was set to ship large fermenting vats to Iraq after the Persian Gulf War, says Alibek. "Fortunately, the sale was not completed. I have no doubt that these fermenters were destined for use in biological weapons production… [T]he particular fermenter size involved in this proposed sale would not be suitable for efficient single-cell protein production."
"Similarly, in 1990," Alibek says, "Biopreparat [the Soviet's key biowarfare entity] was negotiating the sale of dual-use equipment to Cuba."
But Alibek concedes that the readily transparent Iraqi ruse is a different animal from whatever is happening covertly on or under Castro's communist island.
'Strong Suspicions'
Alibek does not have any direct knowledge that Cuba is experimenting with biological weapons, only "strong suspicions," which he first brought to light in his 1999 book. According to Alibek, his former boss, Maj. Gen. Yuri Kalinin, said he thought Cuba had an active bacteriological arms program. However, Alibek concedes, Kalinin told him he never actually saw any weapons being produced.
"There are a few small differences in producing vaccines and weapons," Alibek warns. "But the knowledge is essentially the same."
According to Alibek, Cuba has the sophisticated fermentation vats needed to manufacture both vaccines and pathogens. But as to whether the Cuban biotechnology effort is more or less a front for more sinister R & D exports, the expert wavers.
However, Alibek says, he has always been puzzled by the emphasis of Cuba's biotechnology program on drug production instead of agriculture. "It's quite interesting that a poor country has this type of expertise in biotechnology when its people are hungry."
The bare economic figures also add to Alibek's puzzlement.
Adding Up the Numbers
Castro has injected an estimated $1 billion into biotechnology over the last 16 years. But despite the heralded development of a number of novel medicines, there has been no apparent payoff to justify the costs. Cuba's biotech industry's annual sales fluctuate only between $45 million and $125 million and rank behind prosaic seafood exports.
Yet beyond these relatively sinister facts and figures lurks the discomfiting long history of the Cuban love affair with biotechnology.
According to the Castro myth, less than a year after he led his revolutionaries out of the mountains to seize power in 1959, the 33-year-old head of state made a speech irrevocably linking Cuba's future not to tourism or tobacco - but to science.
In the 1960s, the foundations of the eccentric Castro dream were laid down in the form of a Havana research base modeled after the U.S. National Institutes of Health.
Over the next two decades, thousands of bright Cuban scientists were trained to staff the base at home, in the Soviet Union, Canada, France, Sweden and the United Kingdom.
By the early 1980s, Castro's special preoccupation with biotechnology was fueled by interferon, then seen as an important anti-cancer agent.
The rest is history.
Castro now brags to the world that his Cuban scientists have registered 24 new medicines and vaccines, 49 generic medicines, five products for containing AIDS, and 15 novel pieces of medical equipment. Polo Cientifico, the original research base, has blossomed into a science cluster on the outskirts of Havana that boasts a small city of sleek and modern laboratories.
In April, Cuban scientists will travel to Toronto, Canada, to attend "BIO 2002," the International Biotechnology Convention & Exhibition. Sponsored by the Biotechnology Industry Organization, the U.S. biotech lobbying organization, the annual convention is expected to draw some 15,000 biotech professionals.
Despite the nettlesome American embargo, the Cuban representatives will work hard at the convention pitching the virtues of doing business with the communist regime.
Cuban Credibility
And the Cubans come equipped with plenty of credibility, including a history of manufacturing genetically engineered vaccines against hepatitis B and meningitis B, which Cuba ships to India and former Soviet republics and throughout Latin America.
According to Jose de la Fuente, the former director of research and development at Havana's Center for Genetic Engineering and Biotechnology, Cuba has also innocuously sold production technology for hepatitis B vaccine to Iran.
But, counter U.S. officials, "It's not clear what Cuba has gotten out of this relationship [with Iran]. It is clear that Iran has obtained a considerable amount of weapons technology. In many cases, Russia has used Cuba as a front for technology that Moscow cannot transfer."
Other recipients of Cuban biotechnology research include India, China, Brazil, Egypt, Malaysia, South Africa, Tunisia, Algeria, Great Britain, Venezuela and Mexico.
And if you believe Castro's line, negotiations are under way with several other nations and U.S. pharmaceutical companies that, despite all the obstacles, have professed interest in Cuba's anti-meningitis vaccine and possible clinical trials with a Cuban vaccine for lung cancer. Other goodies in the Cuban pipeline: A medication made from mango peels that targets oxidant stress is sure to be a success on the international market.
The product, "Vimang," is claimed to be an anti-inflammatory, anti-spasmodic and immune system regulator, and is manufactured as a cream, tablets and flavored powder.
Getting Around the Embargo Years ago, the British company Smith Kline Beecham succeeded in persuading Washington to give it an exemption from the embargo, allowing it to develop and market a Cuban vaccine against the child-killing disease meningitis B. Another British outfit, York Medical, has conducted clinical trials of Cuban cancer vaccines and antibodies. To date the company has licensed three anti-cancer therapeutic drugs, a cancer vaccine and a topical anti-fungal.
Currently, thousands of Cuban scientists laboring at 38 institutes continue to refine products for treatment of cancers of the lung, head, neck, breast and ovaries, as well as chemo-therapeutics derived from snake venom, an epidermal growth factor, and a recombinant vaccine against ticks.
Castro's ultimate propaganda message is that his country is selflessly working to provide affordable life-saving meds to an overlooked Third World still dying in droves from AIDS and even cholera. If all this is but a covering ruse to proliferate forbidden technologies to dangerous foes, it is that much more dangerous and sinister.
Experts like Alibek, who have been to the dark side, are very skeptical of Cuba's intentions - despite all the window dressing.
************************
By Dave Eberhart
NewsMax
La Nueva Cuba
May 22, 2002
The former head of Russia's biological weapons program and the man considered to be the foremost expert in the field of bioweapons told NewsMax he has "strong suspicions" that Cuba is developing deadly pathogens.
Questions about Cuba's biological development program were defined recently by three separate charges.
First, an undersecretary of state announced, "The U.S believes that Cuba has at least a limited offensive biological warfare research and development effort."
Second, a spokesman for dictator Fidel Castro dismissed the slur as "loathsome." And finally, former President Jimmy Carter chimed in that the U.S. had no hard evidence that Cuba is sending material for terrorist weapons to other nations.
The foremost expert on the controversial subject, 1992 defector to the U.S. and author of "Biohazard, Dr. Ken Alibek, said he suspects the Bush administration is correct when it says Cuba is developing deadly germ agents.
Alibek notes that a bioweapons program can be masked easily by a civilian-purpose biotechnology effort.
Alibek drew a parallel with Iraq, which he says in the 1980s ran an infamous program to turn the smallpox virus into a biological weapon for the Soviets.
The Iraqis, he said, used the guise of single-cell protein production as a cover for biological weapons facilities.
Russia was set to ship large fermenting vats to Iraq after the Persian Gulf War, says Alibek. "Fortunately, the sale was not completed. I have no doubt that these fermenters were destined for use in biological weapons production… [T]he particular fermenter size involved in this proposed sale would not be suitable for efficient single-cell protein production."
"Similarly, in 1990," Alibek says, "Biopreparat [the Soviet's key biowarfare entity] was negotiating the sale of dual-use equipment to Cuba."
But Alibek concedes that the readily transparent Iraqi ruse is a different animal from whatever is happening covertly on or under Castro's communist island.
'Strong Suspicions'
Alibek does not have any direct knowledge that Cuba is experimenting with biological weapons, only "strong suspicions," which he first brought to light in his 1999 book. According to Alibek, his former boss, Maj. Gen. Yuri Kalinin, said he thought Cuba had an active bacteriological arms program. However, Alibek concedes, Kalinin told him he never actually saw any weapons being produced.
"There are a few small differences in producing vaccines and weapons," Alibek warns. "But the knowledge is essentially the same."
According to Alibek, Cuba has the sophisticated fermentation vats needed to manufacture both vaccines and pathogens. But as to whether the Cuban biotechnology effort is more or less a front for more sinister R & D exports, the expert wavers.
However, Alibek says, he has always been puzzled by the emphasis of Cuba's biotechnology program on drug production instead of agriculture. "It's quite interesting that a poor country has this type of expertise in biotechnology when its people are hungry."
The bare economic figures also add to Alibek's puzzlement.
Adding Up the Numbers
Castro has injected an estimated $1 billion into biotechnology over the last 16 years. But despite the heralded development of a number of novel medicines, there has been no apparent payoff to justify the costs. Cuba's biotech industry's annual sales fluctuate only between $45 million and $125 million and rank behind prosaic seafood exports.
Yet beyond these relatively sinister facts and figures lurks the discomfiting long history of the Cuban love affair with biotechnology.
According to the Castro myth, less than a year after he led his revolutionaries out of the mountains to seize power in 1959, the 33-year-old head of state made a speech irrevocably linking Cuba's future not to tourism or tobacco - but to science.
In the 1960s, the foundations of the eccentric Castro dream were laid down in the form of a Havana research base modeled after the U.S. National Institutes of Health.
Over the next two decades, thousands of bright Cuban scientists were trained to staff the base at home, in the Soviet Union, Canada, France, Sweden and the United Kingdom.
By the early 1980s, Castro's special preoccupation with biotechnology was fueled by interferon, then seen as an important anti-cancer agent.
The rest is history.
Castro now brags to the world that his Cuban scientists have registered 24 new medicines and vaccines, 49 generic medicines, five products for containing AIDS, and 15 novel pieces of medical equipment. Polo Cientifico, the original research base, has blossomed into a science cluster on the outskirts of Havana that boasts a small city of sleek and modern laboratories.
In April, Cuban scientists will travel to Toronto, Canada, to attend "BIO 2002," the International Biotechnology Convention & Exhibition. Sponsored by the Biotechnology Industry Organization, the U.S. biotech lobbying organization, the annual convention is expected to draw some 15,000 biotech professionals.
Despite the nettlesome American embargo, the Cuban representatives will work hard at the convention pitching the virtues of doing business with the communist regime.
Cuban Credibility
And the Cubans come equipped with plenty of credibility, including a history of manufacturing genetically engineered vaccines against hepatitis B and meningitis B, which Cuba ships to India and former Soviet republics and throughout Latin America.
According to Jose de la Fuente, the former director of research and development at Havana's Center for Genetic Engineering and Biotechnology, Cuba has also innocuously sold production technology for hepatitis B vaccine to Iran.
But, counter U.S. officials, "It's not clear what Cuba has gotten out of this relationship [with Iran]. It is clear that Iran has obtained a considerable amount of weapons technology. In many cases, Russia has used Cuba as a front for technology that Moscow cannot transfer."
Other recipients of Cuban biotechnology research include India, China, Brazil, Egypt, Malaysia, South Africa, Tunisia, Algeria, Great Britain, Venezuela and Mexico.
And if you believe Castro's line, negotiations are under way with several other nations and U.S. pharmaceutical companies that, despite all the obstacles, have professed interest in Cuba's anti-meningitis vaccine and possible clinical trials with a Cuban vaccine for lung cancer. Other goodies in the Cuban pipeline: A medication made from mango peels that targets oxidant stress is sure to be a success on the international market.
The product, "Vimang," is claimed to be an anti-inflammatory, anti-spasmodic and immune system regulator, and is manufactured as a cream, tablets and flavored powder.
Getting Around the Embargo Years ago, the British company Smith Kline Beecham succeeded in persuading Washington to give it an exemption from the embargo, allowing it to develop and market a Cuban vaccine against the child-killing disease meningitis B. Another British outfit, York Medical, has conducted clinical trials of Cuban cancer vaccines and antibodies. To date the company has licensed three anti-cancer therapeutic drugs, a cancer vaccine and a topical anti-fungal.
Currently, thousands of Cuban scientists laboring at 38 institutes continue to refine products for treatment of cancers of the lung, head, neck, breast and ovaries, as well as chemo-therapeutics derived from snake venom, an epidermal growth factor, and a recombinant vaccine against ticks.
Castro's ultimate propaganda message is that his country is selflessly working to provide affordable life-saving meds to an overlooked Third World still dying in droves from AIDS and even cholera. If all this is but a covering ruse to proliferate forbidden technologies to dangerous foes, it is that much more dangerous and sinister.
Experts like Alibek, who have been to the dark side, are very skeptical of Cuba's intentions - despite all the window dressing.
************************
CASTRO WEAPONIZES WEST NILE VIRUS
Castro already has used biochemical warfare against South African and UNITA troops.
By Martin Arostegui
Media Credit: UPI
Insight Magazine
Washington
Colaboración:
Nemesio J. Viso
Washington
La Nueva Cuba
Septiembre 16, 2002
As the Bush administration prepares for war with Iraq a growing threat to its rear flank is being ignored, according to senior officials who believe that Cuba's biological-weapons (BW) program is at more advanced stages than officially is acknowledged. There now are reports that P-4 containment systems used to store the deadliest toxins have been identified at suspected bioweapons labs inside Cuba.
A member of the intelligence community expresses concern, but says that an open hearing on this issue would provide "feedback" to Cuba on "how much we know about its BW effort." Undersecretary of State for Arms Control and International Security John Bolton, the source says, was scheduled to deliver details of the Cuban program to the Senate Foreign Relations Committee in June, but the testimony was suppressed by the intelligence bureaucracy.
In his gagged statement, a copy of which was obtained by Insight, Bolton expresses "frustration" at the apparent unwillingness of U.S. intelligence agencies to disclose information about Cuba's biological weapons which could include anthrax, smallpox and variants of encephalitis such as West Nile virus. Recent outbreaks of West Nile virus that have killed more than 30 Americans and infected another 675 have been traced to birds that may have been infected at Cuban bioweapons labs, according to defecting scientists who report Fidel Castro's experiments using animals as carriers of weaponized germ agents.
Carlos Wotzkow, a leading Cuban ornithologist who defected in 1999, says that Castro's "Biological Front, which coordinates military and scientific research, was extended to the Institute of Zoology in 1991 to develop ways of spreading infectious diseases, including encephalitis and leptospirosis, through implantations in migratory birds."
Roberto Hernandez, another exiled Cuban scientist, says, "We were instructed to look into viruses such as encephalitis which are highly resistant to insecticides. Military-intelligence officers running the labs ordered us to trap birds with migratory routes to the United States with the idea of releasing contaminated flocks which would be bitten by mosquitoes which, in turn, infect humans."
A dead crow infected with West Nile virus recently was discovered on the White House lawn, according to the Washington Post. Sixty similarly infected birds fell around the U.S. Navy base in Boca Chica, Fla., during September 2001, causing an encephalitis epidemic that killed a civilian employee.
Scenarios worthy of Stephen King's sci-fi horrors are corroborated by Col. Alvaro Prendes, a former vice chief of the Cuban air force and exiled leader of Union de Soldados y Oficiales Libres (USOL), a clandestine pro-democracy movement within Cuba's armed forces. He tells Insight that Castro's biotech facilities operate under the close control of a colonel of the Directorate of General Intelligence (DGI), Librado Reina Benitan, a longtime protégé of Raul Castro, Cuba's defense minister and brother of Fidel Castro [see "Fidel Castro's Deadly Secret," July 20, 1998].
One fortified compound near a military hospital in east Havana is the size of two football fields and contains six giant bubbles to retain toxic gases. It is fronted as a cattle-feed producer, according to documents smuggled out of Cuba by military dissidents. The laboratory is equipped with a 10,000 Reid vapor-pressure centrifugal reactor and has its own water system and backup generators. It is in any case supported by high-priority circuits that feed a nearby artillery base storing Russian-made SS-22 medium-range missiles capable of reaching south Florida, according to Cuban documents obtained by Insight.
"Castro plans a Götterdämmerung if his regime becomes seriously threatened by an invasion or internal upheaval," warns Prendes, citing a doomsday plan that is code-named Lucero. "Known dissidents would be rounded up and herded into tunnels beneath Havana to be exterminated with poison gas," according to the former fighter pilot who was close to Castro and was decorated as a "hero of the revolution" for shooting down CIA-manned bombers during the aborted Bay of Pigs operation in 1961.
Cuba already has some experience using weaponized poison gas, having employed it against South African troops and forces from the National Union for the Total Independence of Angola (UNITA), according to Aubin Heyndrickx, a senior U.N. consultant on chemical warfare. Cuban-supported rebels of the Revolutionary Armed Forces of Colombia also used poison gas in an attack on the Colombian town of San Adolfo last year, according to an analysis of bomb residues by the U.S. Army's chemical- and biological-warfare center at Fort Detrick in Maryland.
But despite the publicly available evidence presented by highly authoritative sources, U.S. officials are not cleared to make unambiguous statements about Cuba's bioweapons threat. And it has yet to be mentioned by the president or any member of his Cabinet. The CIA's national intelligence officer for Latin America, Fulton Armstrong, is "coordinating talking points" on the issue. But when contacted by Insight he declined comment.
While U.S. intelligence agencies understandably are reluctant to reveal classified material that might compromise methods and informants, a variety of sources in the State Department, the Pentagon, congressional staffs and among media professionals covering national security confirm that Clinton holdovers who retain key positions in the intelligence agencies are using their authority to mislead public opinion on Cuba. This is especially galling to members of the Bush national-security team, and they are known to be complaining loudly about it.
The pro-Castro clique under Bill Clinton was nothing if not brazen. When the British Broadcasting Corp. (BBC) was researching a segment on Cuba for its internationally acclaimed 1998 TV documentary on the proliferation of biochemical weapons to rogue states, Clinton's national-security shop defended Castro at every turn. "A member of the U.S. intelligence community discredited published reports about Cuba's biowarfare capabilities," a BBC executive producer tells Insight, "saying that no Russian scientists involved in the former Soviet Union's biological-weapons program had ever worked in Cuba."
That was disinformation. Ken Alibek, former deputy director of the Soviet Biopreparat, reveals in his 1999 book, Biohazard, that Castro obtained bioweapon technology directly from top-ranking Biopreparat generals and scientists who made repeated trips to Cuba to provide advice and training during the late 1980s and early 1990s. "We knew that Cuba was interested in biowarfare research. We knew that there were several centers, one of them very close to Havana, involved in military biotechnology," Alibek told a congressional hearing last year. He called the contradictory U.S. government statements on Cuban bioweapons a "confusing situation."
Why this fog has been allowed to persist into the Bush administration is even more confusing, if that is the euphemism, say critics. While Bolton was blowing the whistle on Cuba's biowarfare threat in a speech to the Heritage Foundation on May 6, a top CIA analyst identified as a former member of Clinton's National Security Council (NSC) team and a known advocate of rapprochement with Cuba, was telling Jimmy Carter that there was no evidence to support Bolton's accusations. Carter then embarrassed the administration by citing this U.S. intelligence briefing during a press conference in Havana following a tour of a suspected biochemical lab at the invitation of Fidel Castro.
"There is sufficient information to alert the American public, which deserves to know about the developing threat from Cuba," says Bolton. His view is supported by John Ford, head of the State Department Bureau of Intelligence and Research, who on June 5 told an open congressional hearing that "Cuba does indeed have an offensive biological-weapons research program."
Bolton's more sharply worded statement also criticized "a tendency to underplay Cuba." He drew attention to the case of Ana Belen Montes, a Defense Intelligence Agency (DIA) analyst who has pleaded guilty to charges of spying for Castro after being caught red-handed communicating with her DGI handlers in the wake of the Sept. 11 attacks.
"Montes used her position at the Pentagon to try to delete Cuba from the national-security list and influence her colleagues," says Rep. Lincoln Diaz-Balart (R-Fla.), who is trying to condition current legislation easing Cuban travel restrictions upon presidential certifications that biological weapons are not being developed on the island. Staffers of the House and Senate intelligence and foreign-relations committees tell Insight that there nonetheless is resistance within the intelligence bureaucracy to "reviewing assessments filed by Montes which underplay Cuban biowarfare capabilities and discredit defectors warning of the danger."
Constantine Menges, a former NSC officer and CIA analyst, says, "We are looking at the same type of intelligence failure which led to last year's Sept. 11 attacks. I don't think it's as much a case of ideological conspiracy as of our intelligence community not wanting to admit that they have been asleep at the switch."
Encouraging the inertia are pressures from an increasingly powerful business lobby of food producers, farming interests and pharmaceutical companies eager to trade with Cuba. Proof of Cuba's biowarfare activities likely would poison congressional support to lift the economic embargo. Sen. Barbara Boxer (D-Calif.), currently a supporter of easing trade restrictions, says, "If it is true that Cuba has biological weapons it would be very serious and we would have to act on this. It would be an entirely new ball game."
Aside from the direct threat that Cuba's bioweapon capabilities pose to U.S. security, senior administration officials, who include Special Negotiator for Chemical and Biological Weapons Donald Mahley, also worry about ongoing Cuban transfers of dual-use biotechnology to Islamic countries closely connected to Middle Eastern terrorist networks. Castro's vice president, Carlos Lage, inaugurated a new biotechnology-research plant in Iran in 2000, purportedly producing Hepatitis B vaccines. According to José de la Fuente, the former director of research at Cuba's Center for Biological Investigations and Genetics, the transferred technology involves biological agents, pathogens and germ-strengthening processes that also are applicable to weaponizing bacteria.
The deal with Iran was transacted through banks in the United Arab Emirates (UAE), which was Castro's next stop following a state visit to Tehran last year during an Islamic tour that also included the terrorist states of Libya and Syria.
A seemingly neutral gulf kingdom with a low international profile, the UAE would seem an odd destination for Castro. But the small oil state is one of the main international money-laundering centers of the Arab world — one where a series of bank accounts and financial companies has been directly linked to al-Qaeda and the Iranian-backed Hezbollah terror network. Debit cards uncovered at al-Qaeda bases in Afghanistan, inspected by Insight, invariably were issued by banks in the UAE.
Alibek explains how Soviet biotechnology simultaneously was transferred to Cuba, Iran, Iraq and other former Russian allies that share similar bioweapons programs: "The Soviet Union organized courses in genetic engineering and molecular biology for scientists from Eastern Europe, Cuba, Libya, Iran and Iraq. Some 40 foreign scientists were trained annually. Many of them now head biotechnology programs in their own countries."
According to Alibek, Iraq copied Cuban methods to cover up acquisitions of bioweapons technology, such as large industrial fermentation vessels and related equipment. "The model was one we had used to develop and manufacture bacterial biological weapons. Like Cuba, the Iraqis maintained the vessels were intended to grow single-cell protein for cattle feed. What made the deals particularly suspicious were additional requests for exhaust-filtration equipment capable of achieving 99.99 percent air purity — a level we only used in our bioweapons labs," says the world's top biowarfare expert.
On Nov. 4, 2001, Castro was delivering an informal two-hour chat on Havana television about the war on terrorism. He said that Afghanistan was going to be a new Vietnam, that it would take the United States 20 years to defeat the Taliban and that al-Qaeda never would be destroyed. In a brief sound bite that piqued the interest of some U.S. military-intelligence analysts, the Maximum Leader also said that 40 envelopes "containing strange powders" had been intercepted in Cuba, of which five were directed to the United States, Pakistan, Italy and Costa Rica.
Yet, despite the reports of Cuba's biowarfare activities and possible involvement in the Sept. 11 attacks [see "Fidel May Be Part of Terror Campaign," Dec. 3, 2001], Castro never has been named as a "person of interest" in the FBI's anthrax investigations, which instead have focused on Stephen Hatfill, a white, Rhodesian-born U.S. Army scientist who more closely fits the profile of a politically correct villain. A former FBI deputy director told CNN on Aug. 25 that he was perplexed as to why the bureau had failed seriously to investigate a "foreign source" for the anthrax mailings to leading politicians and the media.
U.S. investigators appear to be overlooking two Cuban DGI deep-cover agents indicted in Florida on Aug. 4, 2001, who told the FBI that they had obtained jobs in the U.S. Postal Service on instructions from Havana, which wanted studies of post-office security, through which the deadly anthrax letters moved to kill Americans.
Martin Arostegui is a free-lance writer for Insight magazine.
Castro already has used biochemical warfare against South African and UNITA troops.
By Martin Arostegui
Media Credit: UPI
Insight Magazine
Washington
Colaboración:
Nemesio J. Viso
Washington
La Nueva Cuba
Septiembre 16, 2002
As the Bush administration prepares for war with Iraq a growing threat to its rear flank is being ignored, according to senior officials who believe that Cuba's biological-weapons (BW) program is at more advanced stages than officially is acknowledged. There now are reports that P-4 containment systems used to store the deadliest toxins have been identified at suspected bioweapons labs inside Cuba.
A member of the intelligence community expresses concern, but says that an open hearing on this issue would provide "feedback" to Cuba on "how much we know about its BW effort." Undersecretary of State for Arms Control and International Security John Bolton, the source says, was scheduled to deliver details of the Cuban program to the Senate Foreign Relations Committee in June, but the testimony was suppressed by the intelligence bureaucracy.
In his gagged statement, a copy of which was obtained by Insight, Bolton expresses "frustration" at the apparent unwillingness of U.S. intelligence agencies to disclose information about Cuba's biological weapons which could include anthrax, smallpox and variants of encephalitis such as West Nile virus. Recent outbreaks of West Nile virus that have killed more than 30 Americans and infected another 675 have been traced to birds that may have been infected at Cuban bioweapons labs, according to defecting scientists who report Fidel Castro's experiments using animals as carriers of weaponized germ agents.
Carlos Wotzkow, a leading Cuban ornithologist who defected in 1999, says that Castro's "Biological Front, which coordinates military and scientific research, was extended to the Institute of Zoology in 1991 to develop ways of spreading infectious diseases, including encephalitis and leptospirosis, through implantations in migratory birds."
Roberto Hernandez, another exiled Cuban scientist, says, "We were instructed to look into viruses such as encephalitis which are highly resistant to insecticides. Military-intelligence officers running the labs ordered us to trap birds with migratory routes to the United States with the idea of releasing contaminated flocks which would be bitten by mosquitoes which, in turn, infect humans."
A dead crow infected with West Nile virus recently was discovered on the White House lawn, according to the Washington Post. Sixty similarly infected birds fell around the U.S. Navy base in Boca Chica, Fla., during September 2001, causing an encephalitis epidemic that killed a civilian employee.
Scenarios worthy of Stephen King's sci-fi horrors are corroborated by Col. Alvaro Prendes, a former vice chief of the Cuban air force and exiled leader of Union de Soldados y Oficiales Libres (USOL), a clandestine pro-democracy movement within Cuba's armed forces. He tells Insight that Castro's biotech facilities operate under the close control of a colonel of the Directorate of General Intelligence (DGI), Librado Reina Benitan, a longtime protégé of Raul Castro, Cuba's defense minister and brother of Fidel Castro [see "Fidel Castro's Deadly Secret," July 20, 1998].
One fortified compound near a military hospital in east Havana is the size of two football fields and contains six giant bubbles to retain toxic gases. It is fronted as a cattle-feed producer, according to documents smuggled out of Cuba by military dissidents. The laboratory is equipped with a 10,000 Reid vapor-pressure centrifugal reactor and has its own water system and backup generators. It is in any case supported by high-priority circuits that feed a nearby artillery base storing Russian-made SS-22 medium-range missiles capable of reaching south Florida, according to Cuban documents obtained by Insight.
"Castro plans a Götterdämmerung if his regime becomes seriously threatened by an invasion or internal upheaval," warns Prendes, citing a doomsday plan that is code-named Lucero. "Known dissidents would be rounded up and herded into tunnels beneath Havana to be exterminated with poison gas," according to the former fighter pilot who was close to Castro and was decorated as a "hero of the revolution" for shooting down CIA-manned bombers during the aborted Bay of Pigs operation in 1961.
Cuba already has some experience using weaponized poison gas, having employed it against South African troops and forces from the National Union for the Total Independence of Angola (UNITA), according to Aubin Heyndrickx, a senior U.N. consultant on chemical warfare. Cuban-supported rebels of the Revolutionary Armed Forces of Colombia also used poison gas in an attack on the Colombian town of San Adolfo last year, according to an analysis of bomb residues by the U.S. Army's chemical- and biological-warfare center at Fort Detrick in Maryland.
But despite the publicly available evidence presented by highly authoritative sources, U.S. officials are not cleared to make unambiguous statements about Cuba's bioweapons threat. And it has yet to be mentioned by the president or any member of his Cabinet. The CIA's national intelligence officer for Latin America, Fulton Armstrong, is "coordinating talking points" on the issue. But when contacted by Insight he declined comment.
While U.S. intelligence agencies understandably are reluctant to reveal classified material that might compromise methods and informants, a variety of sources in the State Department, the Pentagon, congressional staffs and among media professionals covering national security confirm that Clinton holdovers who retain key positions in the intelligence agencies are using their authority to mislead public opinion on Cuba. This is especially galling to members of the Bush national-security team, and they are known to be complaining loudly about it.
The pro-Castro clique under Bill Clinton was nothing if not brazen. When the British Broadcasting Corp. (BBC) was researching a segment on Cuba for its internationally acclaimed 1998 TV documentary on the proliferation of biochemical weapons to rogue states, Clinton's national-security shop defended Castro at every turn. "A member of the U.S. intelligence community discredited published reports about Cuba's biowarfare capabilities," a BBC executive producer tells Insight, "saying that no Russian scientists involved in the former Soviet Union's biological-weapons program had ever worked in Cuba."
That was disinformation. Ken Alibek, former deputy director of the Soviet Biopreparat, reveals in his 1999 book, Biohazard, that Castro obtained bioweapon technology directly from top-ranking Biopreparat generals and scientists who made repeated trips to Cuba to provide advice and training during the late 1980s and early 1990s. "We knew that Cuba was interested in biowarfare research. We knew that there were several centers, one of them very close to Havana, involved in military biotechnology," Alibek told a congressional hearing last year. He called the contradictory U.S. government statements on Cuban bioweapons a "confusing situation."
Why this fog has been allowed to persist into the Bush administration is even more confusing, if that is the euphemism, say critics. While Bolton was blowing the whistle on Cuba's biowarfare threat in a speech to the Heritage Foundation on May 6, a top CIA analyst identified as a former member of Clinton's National Security Council (NSC) team and a known advocate of rapprochement with Cuba, was telling Jimmy Carter that there was no evidence to support Bolton's accusations. Carter then embarrassed the administration by citing this U.S. intelligence briefing during a press conference in Havana following a tour of a suspected biochemical lab at the invitation of Fidel Castro.
"There is sufficient information to alert the American public, which deserves to know about the developing threat from Cuba," says Bolton. His view is supported by John Ford, head of the State Department Bureau of Intelligence and Research, who on June 5 told an open congressional hearing that "Cuba does indeed have an offensive biological-weapons research program."
Bolton's more sharply worded statement also criticized "a tendency to underplay Cuba." He drew attention to the case of Ana Belen Montes, a Defense Intelligence Agency (DIA) analyst who has pleaded guilty to charges of spying for Castro after being caught red-handed communicating with her DGI handlers in the wake of the Sept. 11 attacks.
"Montes used her position at the Pentagon to try to delete Cuba from the national-security list and influence her colleagues," says Rep. Lincoln Diaz-Balart (R-Fla.), who is trying to condition current legislation easing Cuban travel restrictions upon presidential certifications that biological weapons are not being developed on the island. Staffers of the House and Senate intelligence and foreign-relations committees tell Insight that there nonetheless is resistance within the intelligence bureaucracy to "reviewing assessments filed by Montes which underplay Cuban biowarfare capabilities and discredit defectors warning of the danger."
Constantine Menges, a former NSC officer and CIA analyst, says, "We are looking at the same type of intelligence failure which led to last year's Sept. 11 attacks. I don't think it's as much a case of ideological conspiracy as of our intelligence community not wanting to admit that they have been asleep at the switch."
Encouraging the inertia are pressures from an increasingly powerful business lobby of food producers, farming interests and pharmaceutical companies eager to trade with Cuba. Proof of Cuba's biowarfare activities likely would poison congressional support to lift the economic embargo. Sen. Barbara Boxer (D-Calif.), currently a supporter of easing trade restrictions, says, "If it is true that Cuba has biological weapons it would be very serious and we would have to act on this. It would be an entirely new ball game."
Aside from the direct threat that Cuba's bioweapon capabilities pose to U.S. security, senior administration officials, who include Special Negotiator for Chemical and Biological Weapons Donald Mahley, also worry about ongoing Cuban transfers of dual-use biotechnology to Islamic countries closely connected to Middle Eastern terrorist networks. Castro's vice president, Carlos Lage, inaugurated a new biotechnology-research plant in Iran in 2000, purportedly producing Hepatitis B vaccines. According to José de la Fuente, the former director of research at Cuba's Center for Biological Investigations and Genetics, the transferred technology involves biological agents, pathogens and germ-strengthening processes that also are applicable to weaponizing bacteria.
The deal with Iran was transacted through banks in the United Arab Emirates (UAE), which was Castro's next stop following a state visit to Tehran last year during an Islamic tour that also included the terrorist states of Libya and Syria.
A seemingly neutral gulf kingdom with a low international profile, the UAE would seem an odd destination for Castro. But the small oil state is one of the main international money-laundering centers of the Arab world — one where a series of bank accounts and financial companies has been directly linked to al-Qaeda and the Iranian-backed Hezbollah terror network. Debit cards uncovered at al-Qaeda bases in Afghanistan, inspected by Insight, invariably were issued by banks in the UAE.
Alibek explains how Soviet biotechnology simultaneously was transferred to Cuba, Iran, Iraq and other former Russian allies that share similar bioweapons programs: "The Soviet Union organized courses in genetic engineering and molecular biology for scientists from Eastern Europe, Cuba, Libya, Iran and Iraq. Some 40 foreign scientists were trained annually. Many of them now head biotechnology programs in their own countries."
According to Alibek, Iraq copied Cuban methods to cover up acquisitions of bioweapons technology, such as large industrial fermentation vessels and related equipment. "The model was one we had used to develop and manufacture bacterial biological weapons. Like Cuba, the Iraqis maintained the vessels were intended to grow single-cell protein for cattle feed. What made the deals particularly suspicious were additional requests for exhaust-filtration equipment capable of achieving 99.99 percent air purity — a level we only used in our bioweapons labs," says the world's top biowarfare expert.
On Nov. 4, 2001, Castro was delivering an informal two-hour chat on Havana television about the war on terrorism. He said that Afghanistan was going to be a new Vietnam, that it would take the United States 20 years to defeat the Taliban and that al-Qaeda never would be destroyed. In a brief sound bite that piqued the interest of some U.S. military-intelligence analysts, the Maximum Leader also said that 40 envelopes "containing strange powders" had been intercepted in Cuba, of which five were directed to the United States, Pakistan, Italy and Costa Rica.
Yet, despite the reports of Cuba's biowarfare activities and possible involvement in the Sept. 11 attacks [see "Fidel May Be Part of Terror Campaign," Dec. 3, 2001], Castro never has been named as a "person of interest" in the FBI's anthrax investigations, which instead have focused on Stephen Hatfill, a white, Rhodesian-born U.S. Army scientist who more closely fits the profile of a politically correct villain. A former FBI deputy director told CNN on Aug. 25 that he was perplexed as to why the bureau had failed seriously to investigate a "foreign source" for the anthrax mailings to leading politicians and the media.
U.S. investigators appear to be overlooking two Cuban DGI deep-cover agents indicted in Florida on Aug. 4, 2001, who told the FBI that they had obtained jobs in the U.S. Postal Service on instructions from Havana, which wanted studies of post-office security, through which the deadly anthrax letters moved to kill Americans.
Martin Arostegui is a free-lance writer for Insight magazine.
posted by PPAC @ 3/03/2007 06:56:00 a. m.
0 comments
0 Comments:
Publicar un comentario
<< Home